Everbridge Unveils COVID-19 ‘Return to Work’ Software Solution to Help Businesses and Governments Improve Safety for Employees and Citizens as They Integrate Back to Public Spaces
5.5.2020 14:00:00 EEST | Business Wire | Press release
Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today unveiled its COVID-19 Return to Work software solution to help businesses and governments navigate the unprecedented complexity of operating during the next phase of the COVID-19 pandemic – preparing to bring back the workforce and reopen society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005390/en/
Everbridge COVID-19 Return to Work software solution
As the industry leader in critical event management solutions, Everbridge serves over 5,000 enterprise customers, 1,500 healthcare entities, 3,700 first responder agencies, and the populations of entire states and countries around the world. As organizations pivot to get back to normal activity, Everbridge’s new Return to Work solution enables businesses to manage the complexity of diverse city, state, and country guidelines and mandates that will evolve dynamically over time, as well as ensures compliance with a full audit trail. Everbridge helps businesses manage all of this complexity through real-time risk intelligence, based on 22,000 data sources across 175 countries, that tracks everything from virus hotspots and travel restrictions, to quarantines and states of emergency, to production stoppages and resumptions, to protests and civil unrest.
The new Everbridge Return to Work solution speeds up contact tracing efforts by providing an automated approach to tracking an individual’s exposure to the virus at work, drawing upon 225 pre-existing, out-of-the-box integrations with such systems as calendaring applications, corporate travel itineraries, building access control, and visitor management. Everbridge enables over 100 communication modalities, including its mobile app, to communicate with and provide real-time feedback from employees, such as wellness checks, which can be used to determine who are candidates to return to work. Overall, Everbridge digitizes and automates the end-to-end return-to-work process while dramatically improving the response time to prevent unnecessary exposure to the virus when days and even hours matter.
Health organizations such as The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend that return to work best practices should require employers to monitor employee health through testing, wellness checks and self-reporting (where employees identify how they are feeling through an app, such as the Everbridge mobile app, on an ‘opt-in’ basis). Contact tracing seeks to identify who else has been exposed to the virus and to coordinate isolation and communications.
“The world’s recovery from the COVID-19 pandemic will be complex, staggered and unpredictable,” said Ajay Nigam, Chief Product Officer at Everbridge. “In the meantime, technology, tools and data are available now to protect people as they return to work, get operations going, and to help governments keep their citizens safe in a better and more efficient manner while protecting privacy. The better handle an organization has on all this complexity, the sooner businesses can return employees to work while governments safely reopen public spaces.”
“As we return to work, it is clear that business is at the forefront of managing the pandemic,” said Nick Allan, CEO at leading specialist risk consultancy, Control Risks. “To keep people safe and a company operating successfully, any international organization will require detailed situational awareness to adhere to diverse and shifting guidelines across potentially hundreds of regions.”
Everbridge’s Return to Work software solution empowers organizations to:
- Automatically leverage the right intelligence, including changing government regulations such as quarantines, curfews, travel bans, new public health policies, and rapidly identify new disease outbreaks.
- Implement, manage and track the tasks for the right protocol at the right location and at the right time, e.g., testing, automated polling of employees or citizens, and enabling mobile wellness checks.
- Accelerate contact tracing by automating the discovery of symptomatic or infected workers – identifying the meetings, buildings, visitors they came in contact with – and mapping against prior travel. Prevent future infections by proactively warning individuals before they enter an incident zone, e.g. an infection hot spot such as an area near a hospital or nursing home, or countries experiencing an increase in outbreaks. Leverage special needs registries to note vulnerable individuals most in need of isolation protocols.
- Integrate polling data from employees or citizens – including results from wellness checks and safety check-ins – into decisions on who can return to work or public spaces.
- Automatically identify and manage impacts to specific assets, supply chain, and transportation routes by tracking production stoppages, closures, and civil unrest, all with a complete audit trail.
- Everbridge also enables governments to anonymously report on crowd movement and population density, without compromising privacy, in order to determine whether groups have achieved more critical mass than is permitted under distancing guidelines, and to verify the success of evacuation efforts.
For city, state, and national governments, Everbridge provides population alerting, incident zone management and citizen polling at country-wide scale, ensuring policies and restrictions are communicated as situations change; aggregates the most comprehensive risk intelligence from the Everbridge Network of public safety, healthcare, transportation and homeland security agencies; quickly ensures evacuations and dispersals have been followed; anonymously monitors crowd movements and previous possible virus exposure of citizens without requiring an app download or infringing privacy.
The Norwegian Directorate for Health, for example, sent a record 5.4 million COVID-19 messages via the Everbridge platform last month to every mobile phone in Norway. The Directorate also sent messages to all non-Norwegian phones roaming inside the country in English, French, German, Spanish, Polish and Russian, providing critical instructions for foreign nationals. Everbridge Public Warning automatically detected the nationality of a person’s mobile device, without the need for any personally identifiable information (PII), and then sent messages in the appropriate language to improve the effectiveness of communication to visitors and international travelers.
The Everbridge Return to Work software solution is immediately available in all markets where Everbridge operates for both corporate and government use cases. To inquire about how an organization can access these tools, please visit Coronavirus Preparedness Hub.
As the global leader in critical event management and public warning, Everbridge and its global platform reach over 550 million people across the world while serving leading F500 companies as well as cities, states, and entire countries.
In response to COVID-19, the Everbridge platform has delivered over 300 million communications specific to coronavirus as well as launched its COVID-19 Shield rapid deployment templates to protect people and maintain operations amid the pandemic. Everbridge also partners with the U.S. Army to mitigate the impact of COVID-19 across over 400 military locations in 70 countries. The company provides daily updates on its Coronavirus Preparedness Hub.
Everbridge also recently announced its “Coronavirus: the Road to Recovery” virtual leadership summit to be held May 20-21, 2020. The conference will feature two marquee keynote speakers: General Colin L. Powell, USA (Ret.), who will speak about leadership in challenging times, and Scott Gottlieb, M.D., former FDA Commissioner, who will discuss a roadmap to recovery. To register and learn more, go to Coronavirus: the Road to Recovery.
About Everbridge
Everbridge, Inc. (NASDAQ: EVBG) is a global software company that provides enterprise software applications that automate and accelerate organizations’ operational response to critical events in order to keep people safe and businesses running. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events including IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 5,000 global customers rely on the company’s Critical Event Management Platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes through the secure delivery to over 100 different communication devices, and track progress on executing response plans. The company’s platform sent over 3.5 billion messages in 2019 and offers the ability to reach over 550 million people in more than 200 countries and territories, including the entire mobile populations on a country-wide scale in Australia, Greece, Iceland, the Netherlands, New Zealand, Peru, Singapore, Sweden, and a number of the largest states in India. The company’s critical communications and enterprise safety applications include Mass Notification, Incident Management, Safety Connection™, IT Alerting, Visual Command Center®, Public Warning, Crisis Management, Community Engagement™ and Secure Messaging. Everbridge serves 8 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, 47 of the 50 busiest North American airports, 9 of the 10 largest global consulting firms, 7 of the 10 largest global auto makers, all 4 of the largest global accounting firms, 9 of the 10 largest U.S.-based health care providers, and 6 of the 10 largest technology companies in the world. Everbridge is based in Boston and Los Angeles with additional offices in Lansing, San Francisco, Abu Dhabi, Beijing, Bangalore, Kolkata, London, Munich, New York, Oslo, Singapore, Stockholm and Tilburg. For more information, visit www.everbridge.com, read the company blog, and follow on LinkedIn, Twitter, and Facebook.
Cautionary Language Concerning Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the anticipated opportunity and trends for growth in our critical communications and enterprise safety applications and our overall business, our market opportunity, our expectations regarding sales of our products, our goal to maintain market leadership and extend the markets in which we compete for customers, and anticipated impact on financial results. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the ability of our products and services to perform as intended and meet our customers’ expectations; our ability to successfully integrate businesses and assets that we may acquire; our ability to attract new customers and retain and increase sales to existing customers; our ability to increase sales of our Mass Notification application and/or ability to increase sales of our other applications; developments in the market for targeted and contextually relevant critical communications or the associated regulatory environment; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate; we have not been profitable on a consistent basis historically and may not achieve or maintain profitability in the future; the lengthy and unpredictable sales cycles for new customers; nature of our business exposes us to inherent liability risks; our ability to attract, integrate and retain qualified personnel; our ability to maintain successful relationships with our channel partners and technology partners; our ability to manage our growth effectively; our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200505005390/en/
Contact information
Media:
Jeff Young
Everbridge
jeff.young@everbridge.com
781-859-4116
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
